MedTrace Logo

CytoSorb in Patients With Liver Failure

NCT04511507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2021-09-05

No results posted yet for this study

Summary

Hemoadsorption has been demonstrated to improve liver functional tests in patients with liver failure. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with acute liver failure, on liver functional tests, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Conditions

  • Liver Dysfunction

Interventions

PROCEDURE

hemoadsorption

three consecutive sessions of hemoadsorption in patients with liver failure

Sponsors & Collaborators

  • Institutul Clinic Fundeni

    lead OTHER

Principal Investigators

  • Dana Tomescu, Prof · Fundeni Clinical Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-10
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04511507 on ClinicalTrials.gov